Perioperative management with biologics on severe aortic valve regurgitation caused by Behçet syndrome: the experience from a single center
Background: To investigate the efficacy and safety of biologics in the perioperative management of severe aortic valve regurgitation (AR) caused by Behçet syndrome (BS). Methods: We retrospectively analyzed 20 patients with severe AR caused by BS who were all treated with biologics during the periop...
Main Authors: | Luxi Sun, Jinjing Liu, Xiufeng Jin, Zhimian Wang, Lu Li, Wei Bai, Yunjiao Yang, Chanyuan Wu, Wei Chen, Shangdong Xu, Jun Zheng, Wenjie Zheng |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2021-06-01
|
Series: | Therapeutic Advances in Chronic Disease |
Online Access: | https://doi.org/10.1177/20406223211026753 |
Similar Items
-
Predictors of paravalvular aortic regurgitation after surgery for Behcet’s disease-related severe aortic regurgitation
by: Hong-Mi Choi, et al.
Published: (2019-06-01) -
Tocilizumab in the treatment of severe and refractory parenchymal neuro-Behçet’s syndrome: case series and literature review
by: Jinjing Liu, et al.
Published: (2020-11-01) -
Aortitis With Severe Aortic Regurgitation in Behcet's Disease: A Case Report
by: Hsin-Hui Chiu, et al.
Published: (2010-01-01) -
Transcatheter aortic valve replacement valve in transcatheter aortic valve replacement valve for severe periprosthetic regurgitation
by: Sneha Nandy, et al.
Published: (2020-01-01) -
A rare cause of severe aortic valve regurgitation: isolated aortic valve prolapse
by: Zeki Yüksel Günaydın, et al.
Published: (2015-03-01)